By Erin Schumaker

The director of national intelligence told podcast host Megyn Kelly she’s working with top HHS officials to investigate Covid-19’s origins.

The director of national intelligence told podcast host Megyn Kelly she’s working with top HHS officials to investigate Covid-19’s origins.

The director of national intelligence told podcast host Megyn Kelly she’s working with top HHS officials to investigate Covid-19’s origins.

The director of national intelligence told podcast host Megyn Kelly she’s working with top HHS officials to investigate Covid-19’s origins.

The director of national intelligence told podcast host Megyn Kelly she’s working with top HHS officials to investigate Covid-19’s origins.

The director of national intelligence told podcast host Megyn Kelly she’s working with top HHS officials to investigate Covid-19’s origins.

The Covid contrarian’s Senate confirmation hearing to lead the National Institutes of Health promises another airing of pandemic grievances.

The Covid contrarian’s Senate confirmation hearing to lead the National Institutes of Health promises another airing of pandemic grievances.

The Covid contrarian’s Senate confirmation hearing to lead the National Institutes of Health promises another airing of pandemic grievances.

The Covid contrarian’s Senate confirmation hearing to lead the National Institutes of Health promises another airing of pandemic grievances.

The Covid contrarian’s Senate confirmation hearing to lead the National Institutes of Health promises another airing of pandemic grievances.

The Covid contrarian’s Senate confirmation hearing to lead the National Institutes of Health promises another airing of pandemic grievances.

The Covid contrarian’s Senate confirmation hearing to lead the National Institutes of Health promises another airing of pandemic grievances.

The Covid contrarian’s Senate confirmation hearing to lead the National Institutes of Health promises another airing of pandemic grievances.

The Maine Republican, the Senate’s top appropriator, said she has HHS nominee Robert F. Kennedy Jr.’s commitment to “re-examine” the cuts.

The Maine Republican, the Senate’s top appropriator, said she has HHS nominee Robert F. Kennedy Jr.’s commitment to “re-examine” the cuts.

The Stanford University physician and economist, known for opposing Covid-19 lockdowns, has been tapped to lead the $47 billion biomedical research agency.

The Stanford University physician and economist, known for opposing Covid-19 lockdowns, has been tapped to lead the $47 billion biomedical research agency.

The Stanford University physician and economist, known for opposing Covid-19 lockdowns, has been tapped to lead the $47 billion biomedical research agency.

The Stanford University physician and economist, known for opposing Covid-19 lockdowns, has been tapped to lead the $47 billion biomedical research agency.

The Stanford University physician and economist, known for opposing Covid-19 lockdowns, has been tapped to lead the $47 billion biomedical research agency.

The Stanford University physician and economist, known for opposing Covid-19 lockdowns, has been tapped to lead the $47 billion biomedical research agency.

The Stanford University physician and economist, known for opposing Covid-19 lockdowns, has been tapped to lead the $47 billion biomedical research agency.

The Stanford University physician and economist, known for opposing Covid-19 lockdowns, has been tapped to lead the $47 billion biomedical research agency.

The Stanford University physician and economist, known for opposing Covid-19 lockdowns, has been tapped to lead the $47 billion biomedical research agency.

The Stanford University physician and economist, known for opposing Covid-19 lockdowns, has been tapped to lead the $47 billion biomedical research agency.

The Stanford University physician and economist, known for opposing Covid-19 lockdowns, has been tapped to lead the $47 billion biomedical research agency.

The Stanford University physician and economist, known for opposing Covid-19 lockdowns, has been tapped to lead the $47 billion biomedical research agency.

The Stanford University physician and economist, known for opposing Covid-19 lockdowns, has been tapped to lead the $47 billion biomedical research agency.